[Federal Register Volume 65, Number 89 (Monday, May 8, 2000)]
[Notices]
[Page 26635]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-11411]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated January 28, 2000, and published in the Federal 
Register on February 9, 2000, (65 FR 27), Mallinckrodt, Inc., 
Mallinckrodt & Second Streets, St. Louis, Missouri 63147, made 
application by letter to the Drug Enforcement Administration (DEA) to 
be registered as a bulk manufacturer of dihydromorphine (9145), a basic 
class of controlled substance listed Schedule I.
    Mallinckrodt, Inc. plans to isolate dihydromorphine as a step in a 
multistep synthesis of hydromorphone.
    DEA has considered the factors in Title 21, United States Code, 
Section 823(a) and determined that the registration of Mallinckrodt, 
Inc. to manufacture dihydromorphine is consistent with the public 
interest at this time. DEA has investigated Mallinckrodt, Inc. on a 
regular basis to ensure that the company's continued registration is 
consistent with the public interest. These investigations have included 
inspection and testing of the company's physical security systems, 
verification of the company's compliance with state and local laws, and 
a review of the company's background and history. Therefore, pursuant 
to 21 U.S.C. 823 and 28 CFR 0.100 and 0.104, the Deputy Assistant 
Administrator, Office of Diversion Control, hereby orders that the 
application submitted by the above firm for registration as a bulk 
manufacturer of the basic class of controlled substance listed above is 
granted.

    Dated: April 25, 2000.
John H. King,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 00-11411 Filed 5-5-00; 8:45 am]
BILLING CODE 4410-09-M